BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 21843610)

  • 21. Peptide-mediated protein delivery-which pathways are penetrable?
    Räägel H; Säälik P; Pooga M
    Biochim Biophys Acta; 2010 Dec; 1798(12):2240-8. PubMed ID: 20170627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems.
    Freire JM; Veiga AS; de la Torre BG; Andreu D; Castanho MA
    J Pept Sci; 2013 Apr; 19(4):182-9. PubMed ID: 23322613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine-rich cell-penetrating peptides deliver gene into living human cells.
    Liu BR; Lin MD; Chiang HJ; Lee HJ
    Gene; 2012 Aug; 505(1):37-45. PubMed ID: 22669044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel method for monitoring the cytosolic delivery of peptide cargo.
    Cheung JC; Kim Chiaw P; Deber CM; Bear CE
    J Control Release; 2009 Jul; 137(1):2-7. PubMed ID: 19285529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell transduction pathways of transportans.
    Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
    Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
    Nakase I; Tanaka G; Futaki S
    Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The uptake of arginine-rich cell-penetrating peptides: putting the puzzle together.
    Brock R
    Bioconjug Chem; 2014 May; 25(5):863-8. PubMed ID: 24679171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9.
    Ziegler A; Seelig J
    Biochemistry; 2011 May; 50(21):4650-64. PubMed ID: 21491915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transduction of peptides and proteins into live cells by cell penetrating peptides.
    Mussbach F; Franke M; Zoch A; Schaefer B; Reissmann S
    J Cell Biochem; 2011 Dec; 112(12):3824-33. PubMed ID: 21826709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arginine-rich peptides and their internalization mechanisms.
    Futaki S; Nakase I; Tadokoro A; Takeuchi T; Jones AT
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):784-7. PubMed ID: 17635148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.
    Zhang R; Yang XZ; Wang JW; Fu LY; Zhao J; Wang FJ
    J Drug Target; 2015 Jun; 23(5):444-52. PubMed ID: 25609361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chances and pitfalls of cell penetrating peptides for cellular drug delivery.
    Tréhin R; Merkle HP
    Eur J Pharm Biopharm; 2004 Sep; 58(2):209-23. PubMed ID: 15296950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.
    Verdurmen WP; Wallbrecher R; Schmidt S; Eilander J; Bovee-Geurts P; Fanghänel S; Bürck J; Wadhwani P; Ulrich AS; Brock R
    J Control Release; 2013 Aug; 170(1):83-91. PubMed ID: 23669260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the attachment of a penetration accelerating sequence and the influence of hydrophobicity on octaarginine-mediated intracellular delivery.
    Takayama K; Hirose H; Tanaka G; Pujals S; Katayama S; Nakase I; Futaki S
    Mol Pharm; 2012 May; 9(5):1222-30. PubMed ID: 22486588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
    Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
    J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane permeation of arginine-rich cell-penetrating peptides independent of transmembrane potential as a function of lipid composition and membrane fluidity.
    Wallbrecher R; Ackels T; Olea RA; Klein MJ; Caillon L; Schiller J; Bovée-Geurts PH; van Kuppevelt TH; Ulrich AS; Spehr M; Adjobo-Hermans MJW; Brock R
    J Control Release; 2017 Jun; 256():68-78. PubMed ID: 28411183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internalization of nucleoside phosphates into live cells by complex formation with different CPPs and JBS-nucleoducin.
    Mussbach F; Pietrucha R; Schaefer B; Reissmann S
    Methods Mol Biol; 2011; 683():375-89. PubMed ID: 21053144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
    Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
    Elife; 2021 Oct; 10():. PubMed ID: 34713805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.